[go: up one dir, main page]

MXPA00002111A - Biomoleculas que contienen un peptido elastomerico. - Google Patents

Biomoleculas que contienen un peptido elastomerico.

Info

Publication number
MXPA00002111A
MXPA00002111A MXPA00002111A MXPA00002111A MXPA00002111A MX PA00002111 A MXPA00002111 A MX PA00002111A MX PA00002111 A MXPA00002111 A MX PA00002111A MX PA00002111 A MXPA00002111 A MX PA00002111A MX PA00002111 A MXPA00002111 A MX PA00002111A
Authority
MX
Mexico
Prior art keywords
biomolecules
elastomeric peptide
elastomeric
peptide
inducibly
Prior art date
Application number
MXPA00002111A
Other languages
English (en)
Inventor
Herald Reiersen
Anthony Rees
Lars Korsnes
Original Assignee
Dynal Biotech Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dynal Biotech Asa filed Critical Dynal Biotech Asa
Publication of MXPA00002111A publication Critical patent/MXPA00002111A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención se refiere a biomoléculas que contienen una secuencia de aminoácidos isertada que comprende un péptido elastómerico el cual se contrae de manera inducible, que en contracción o extensión, altera las propiedades o características de la molécula en la cual se inserta, particularmente biomoléculas tales como anticuerpos, moléculas de ácido nucleíco que codifican tales biomoléculas y el uso de tales biomoléculas..
MXPA00002111A 1997-08-29 1998-08-28 Biomoleculas que contienen un peptido elastomerico. MXPA00002111A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9718463.4A GB9718463D0 (en) 1997-08-29 1997-08-29 Biomolecules
PCT/GB1998/002602 WO1999011661A1 (en) 1997-08-29 1998-08-28 Biomolecules comprising an elastomeric peptide

Publications (1)

Publication Number Publication Date
MXPA00002111A true MXPA00002111A (es) 2010-06-01

Family

ID=10818314

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA00002111A MXPA00002111A (es) 1997-08-29 1998-08-28 Biomoleculas que contienen un peptido elastomerico.

Country Status (11)

Country Link
EP (1) EP1009761A1 (es)
JP (1) JP2001514263A (es)
KR (1) KR20010023510A (es)
CN (1) CN1276796A (es)
AU (1) AU759080B2 (es)
BR (1) BR9811421A (es)
CA (1) CA2301981A1 (es)
GB (1) GB9718463D0 (es)
MX (1) MXPA00002111A (es)
NZ (1) NZ503097A (es)
WO (1) WO1999011661A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19960509A1 (de) * 1999-12-15 2001-07-12 Jan Kristian Krueger Nanoskalierte Funktionsschicht
EP1297010A2 (en) * 2000-06-23 2003-04-02 Bioelastics Research, Ltd. Bioelastomer nanomachines and biosensors
EP2336167B1 (en) 2001-03-14 2019-05-29 Dako Denmark A/S MHC molecule constructs and their uses for diagnosis and therapy
DE10155862A1 (de) * 2001-11-14 2003-05-28 Ipk Inst Fuer Pflanzengenetik Produktion von rekombinanten Antikörpern mittels Fusion mit Elastin-ähnlichen Peptiden
JP2009525946A (ja) * 2005-12-20 2009-07-16 デューク・ユニヴァーシティ 増強された薬理学的性質を有する活性物質を送達するための方法および組成物
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
WO2008116468A2 (en) 2007-03-26 2008-10-02 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
EP3023436A1 (en) 2007-07-03 2016-05-25 Dako Denmark A/S Improved methods for generation, labeling and use of mhc multimers
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
JP5458344B2 (ja) * 2008-01-30 2014-04-02 旭化成株式会社 抗体固定化担体
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
CN102131516B (zh) 2008-06-27 2016-03-16 杜克大学 包含弹性蛋白样肽的治疗剂
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
US12258373B2 (en) 2018-12-17 2025-03-25 Immudex Aps Panel comprising Borrelia MHC multimers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3750223T2 (de) * 1986-04-17 1994-11-10 Uab Research Foundation Segmentierte polypeptid-bioelastomere zur modulierung des elastizitaetsmoduls.
DE3752363T2 (de) * 1986-11-04 2004-02-19 Protein Polymer Technologies, Inc., San Diego Herstellung synthetischer dns und deren verwendung bei der synthese grosser polypeptide
EP0623679B1 (en) * 1987-05-21 2003-06-25 Micromet AG Targeted multifunctional proteins
EP0406357B1 (en) * 1988-11-09 1998-01-07 Protein Polymer Technologies, Inc. Functional recombinantly prepared synthetic protein polymer
DE69105323T2 (de) * 1990-03-27 1995-06-01 Bioelastics Res Ltd Bioelastomeres Arzneimittelabgabesystem.
US5939385A (en) * 1993-08-13 1999-08-17 Zymogenetics, Inc. Transglutaminase cross-linkable polypeptides and methods relating thereto

Also Published As

Publication number Publication date
EP1009761A1 (en) 2000-06-21
BR9811421A (pt) 2000-08-22
CN1276796A (zh) 2000-12-13
KR20010023510A (ko) 2001-03-26
GB9718463D0 (en) 1997-11-05
AU8875598A (en) 1999-03-22
AU759080B2 (en) 2003-04-03
JP2001514263A (ja) 2001-09-11
NZ503097A (en) 2002-03-28
WO1999011661A1 (en) 1999-03-11
CA2301981A1 (en) 1999-03-11

Similar Documents

Publication Publication Date Title
MXPA00002111A (es) Biomoleculas que contienen un peptido elastomerico.
ATE271129T1 (de) Isoliertes p27 protein und nukleinsäure dafür kodierend
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
ATE318905T1 (de) Homologe des tie-rezeptortyrosinekinase liganden
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
CY1110381T1 (el) Πεπτιδια χ-κωνοτοξινης ως αναστολεις των νευρωνικων αμινικων μεταφορεων
WO2002059306A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
FI972170A7 (fi) Peptidejä, jotka kykenevät sitoutumaan GAP-proteiinin SH3-domeeniin, n äitä peptidejä koodittavia nukleotidisekvenssejä, niiden valmistus ja käyttö
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
WO2002046407A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2000000506A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO2001049714A3 (en) Nope polypeptides, encoding nucleic acids and methods of use
EA200100314A1 (ru) Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины
DE59813125D1 (de) Srcr domäne-enthaltendes protein
WO2001081412A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
WO2002077190A8 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002022678A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
GB2329896A (en) Enzyme and DNA sequence encoding same
WO2002033086A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002024748A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002020757A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002046217A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2001088136A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002048366A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002048365A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: CENTRE NATIONAL D ETUDES SPATIALES

FA Abandonment or withdrawal